注册以创建品种、
财经事件和所关注作者内容的提醒
免费注册 已有账户? 登录
HTG Molecular Diagnostics Inc是一家生命科学公司,专注于通过转录组全谱分析技术推进精确医学。该公司的HTG Edge和HTG EdgeSeq平台由仪器、耗材和软件分析组成,用于样本分析应用,包括肿瘤分析、分子诊断测试和生物标记物开发。该公司的HTG Edge和HTG EdgeSeq平台使用其核酸酶保护化学对一系列生物样本进行基因和基因活性的分子分析自动化。该公司的HTG EdgeSeq化学,连同其HTG Edge或HTG EdgeSeq仪器和软件,自动化并调整其核酸酶保护化学,以便使用下一代测序(NGS)仪器进行分析。
名称 | 年龄 | 任期 | 标题 |
---|---|---|---|
Ann F. Hanham | 68 | 2016 | Independent Chairman of the Board |
John L. Lubniewski | 57 | 2011 | President, CEO & Director |
Donnie M. Hardison | 70 | 2016 | Independent Director |
Christopher P. Kiritsy | 57 | 2022 | Non-Employee Independent Director |
Lee R. McCracken | 64 | 2015 | Independent Director |
Robert Spitale | - | 2022 | Member of Therapeutics Scientific Advisory Board |
Michelle Griffin | 56 | 2018 | Independent Director |
Amir Horowitz | - | - | Member of Scientific Advisory Board |
Mateusz Koptyra | - | - | Member of Scientific Advisory Board |
Frank Slack | - | - | Member of Scientific Advisory Board |
Kendall Van Keuren-Jensen | - | - | Member of Scientific Advisory Board |
Davide Ruggero | - | - | Member of Scientific Advisory Board |
Thomas W. Dubensky | 65 | 2022 | Independent Director |
确定屏蔽%USER_NAME%?
如果屏蔽,您和%USER_NAME%都无法看到相互在Investing.com上发布的信息。
%USER_NAME%已成功添加至屏蔽列表
由于您刚刚取消屏蔽此人,因此必须等待48小时才能重新屏蔽。
您举报该评论的原因为:
谢谢您!
您的举报将会被发送到管理员进行审核